Time course of skin toxicity (tox) secondary to erlotinib (E) therapy in patients (pts) with non-small cell lung cancer (NSCLC) enrolled in the SATURN study.
R. Perez-Soler
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
F. Cappuzzo
Consultant or Advisory Role - Roche
Honoraria - Roche
L. Leon
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
S. Wojtowicz-Praga
Employment or Leadership Position - Genentech
Stock Ownership - Roche/Genentech